JMP Securities Downgrades Savient Pharmaceuticals (SVNT) to Market Underperform
Tweet
Share
E-mailGet Alerts SVNT Hot Sheet
Price: $40.05 --0%
Rating Summary:
2 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Rating Summary:
2 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Join SI Premium – FREE
JMP Securities downgraded Savient Pharmaceuticals (NASDAQ: SVNT) from Market Perform to Market Underperform with a new price target of $1.50.
For an analyst ratings summary and ratings history on Savient Pharmaceuticals click here. For more ratings news on Savient Pharmaceuticals click here.
Shares of Savient Pharmaceuticals closed at $2.98 yesterday.
For an analyst ratings summary and ratings history on Savient Pharmaceuticals click here. For more ratings news on Savient Pharmaceuticals click here.
Shares of Savient Pharmaceuticals closed at $2.98 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GLJ Research Downgrades Fluence Energy Inc. (FLNC) to Hold
- Citi cuts Weibo stock rating to Neutral, lowers price target
- Jefferies Downgrades IDP Education (IEL:AU) (IDPUF) to Hold
Create E-mail Alert Related Categories
DowngradesRelated Entities
JMP SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
